Seguir
Gregory Cairncross
Gregory Cairncross
Professor of Clinical Neurosciences, University of Calgary
Dirección de correo verificada de ucalgary.ca
Título
Citado por
Citado por
Año
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp, WP Mason, MJ Van Den Bent, M Weller, B Fisher, ...
New England journal of medicine 352 (10), 987-996, 2005
225892005
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
ME Hegi, AC Diserens, T Gorlia, MF Hamou, N De Tribolet, M Weller, ...
New England Journal of Medicine 352 (10), 997-1003, 2005
84422005
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the …
R Stupp, ME Hegi, WP Mason, MJ Van Den Bent, MJB Taphoorn, ...
The lancet oncology 10 (5), 459-466, 2009
81312009
Response criteria for phase II studies of supratentorial malignant glioma.
DR Macdonald, TL Cascino, SC Schold Jr, JG Cairncross
Journal of clinical oncology 8 (7), 1277-1280, 1990
27851990
Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
JG Cairncross, K Ueki, MC Zlatescu, DK Lisle, DM Finkelstein, ...
JNCI: Journal of the National Cancer Institute 90 (19), 1473-1479, 1998
19041998
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402
G Cairncross, M Wang, E Shaw, R Jenkins, D Brachman, J Buckner, ...
Journal of clinical oncology 31 (3), 337, 2013
12462013
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification
CL Nutt, DR Mani, RA Betensky, P Tamayo, JG Cairncross, C Ladd, ...
Cancer research 63 (7), 1602-1607, 2003
11682003
Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED] Report of the Quality Standards Subcommittee of the American Academy of …
MJ Glantz, BF Cole, PA Forsyth, LD Recht, PY Wen, MC Chamberlain, ...
Neurology 54 (10), 1886-1893, 2000
10232000
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial
W Roa, PMA Brasher, G Bauman, M Anthes, E Bruera, A Chan, B Fisher, ...
Journal of clinical oncology 22 (9), 1583-1588, 2004
10202004
Short-course radiation plus temozolomide in elderly patients with glioblastoma
JR Perry, N Laperriere, CJ O’Callaghan, AA Brandes, J Menten, C Phillips, ...
New England Journal of Medicine 376 (11), 1027-1037, 2017
10162017
European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of …
R Stupp, ME Hegi, WP Mason, MJ van den Bent, MJ Taphoorn, ...
Lancet Oncol 10 (5), 459-466, 2009
10132009
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group …
G Cairncross, B Berkey, E Shaw, R Jenkins, B Scheithauer, D Brachman, ...
J Clin Oncol 24 (18), 2707-2714, 2006
8642006
Stem cell–related “self-renewal” signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
A Murat, E Migliavacca, T Gorlia, WL Lambiv, T Shay, MF Hamou, ...
Journal of clinical oncology 26 (18), 3015-3024, 2008
8152008
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3
T Gorlia, MJ van den Bent, ME Hegi, RO Mirimanoff, M Weller, ...
The lancet oncology 9 (1), 29-38, 2008
6412008
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review
N Laperriere, L Zuraw, G Cairncross, ...
Radiotherapy and Oncology 64 (3), 259-273, 2002
6382002
Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
RO Mirimanoff, T Gorlia, W Mason, MJ Van den Bent, RD Kortmann, ...
J Clin Oncol 24 (16), 2563-2569, 2006
6292006
Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis
Y Ino, RA Betensky, MC Zlatescu, H Sasaki, DR Macdonald, ...
Clinical Cancer Research 7 (4), 839-845, 2001
5552001
Radation therapy for brain metastases
JG Cairncross, JH Kim, JB Posner
Annals of Neurology: Official Journal of the American Neurological …, 1980
5531980
Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.
G Cairncross, D Macdonald, S Ludwin, D Lee, T Cascino, J Buckner, ...
Journal of Clinical Oncology 12 (10), 2013-2021, 1994
5371994
Changing paradigms—an update on the multidisciplinary management of malignant glioma
R Stupp, ME Hegi, MJ Van Den Bent, WP Mason, M Weller, ...
The oncologist 11 (2), 165-180, 2006
4882006
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20